Clarification of Implementation of the NIH SBIR and STTR Foreign Disclosure Pre-award and Post-Award Requirements

Purpose
The purpose of this Notice is to provide clarification regarding findings of foreign involvement with countries of concern related to grants and cooperative agreements. The specific changes implemented in NOT-OD-23-139 and clarified in the current Notice apply to all competing applications for funding under the NIH, CDC, and FDA SBIR and STTR programs submitted for due dates on or after September 5, 2023.

Clarification of Specific Changes to Competing Application Instructions

NIH has revised the guidance to outline the fact that generally, for competing applications submitted for funding under the NIH, CDC, and FDA SBIR and STTR programs for due dates on or after September 5, 2023, NIH, CDC, and FDA will not mitigate security risks identified as part of the due diligence program.

Therefore, the sections regarding risk mitigation have been modified to read as follows (changes in bold italics). All other portions of NOT-OD-23-139 remain applicable.

More Info : https://grants.nih.gov/grants/guide/notice-files/NOT-OD-24-029.html

Last Updated on November 21, 2023